Testing effectiveness (Phase 2)Study completedNCT03954327What this trial is testingCombination Antiretroviral Therapy (cART) for PBCWho this might be right forPrimary Biliary Cholangitis University of Alberta 37
Very early researchLooking for participantsNCT04657861What this trial is testingAPRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma in RelapseMultiple Myeloma, Refractory Zhejiang University 36
Not applicableNot Yet RecruitingNCT06472479What this trial is testingLCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple MyelomaWho this might be right forRelapsed/Refractory Multiple Myeloma The First Affiliated Hospital with Nanjing Medical University 66
Early research (Phase 1)UnknownNCT03825146What this trial is testingThe Effects of AMPC in the Treatments of Refractory or Relapsed AMLWho this might be right forAcute Myeloid Leukaemia Recurrent Lai Corporation Pty. Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT00195624What this trial is testingAlemtuzumab to Treat Severe Aplastic AnemiaWho this might be right forSevere Aplastic Anemia, RefractorySevere Aplastic Anemia, Relapse National Heart, Lung, and Blood Institute (NHLBI) 47
Testing effectiveness (Phase 2)Study completedNCT02332980What this trial is testingPembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin LymphomasWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue+20 more Mayo Clinic 65
Testing effectiveness (Phase 2)Study completedNCT03390296What this trial is testingOX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00006890What this trial is testingThalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm NCIC Clinical Trials Group 67
Testing effectiveness (Phase 2)Study completedNCT03439280What this trial is testingInvestigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)Who this might be right forRelapsed/RefractoryMultiple Myeloma Millennium Pharmaceuticals, Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT07264803What this trial is testingA Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to Guide Treatment in Previously Treated CancersWho this might be right forSolid Tumor MalignanciesSolid Tumor Cancer Qilu Hospital of Shandong University 35
Testing effectiveness (Phase 2)Study completedNCT00662727What this trial is testingExtracorporeal Shockwave Therapy for the Treatment of Refractory Angina PectorisWho this might be right forRefractory Angina Pectoris Medispec 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT06655896What this trial is testingPhase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic SclerosisWho this might be right forScleroderma, Diffuse Novartis Pharmaceuticals 96
Not applicableStudy completedNCT03251703What this trial is testingUltrasound-Guided Suprascapular Pulsed RadiofrequencyWho this might be right forPAIN, INTRACTABLE, Shoulder Sakarya University 74
Not applicableUnknownNCT04773769What this trial is testingStudy of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade LymphomasWho this might be right forGastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal JunctionHepatocellular Carcinoma+3 more Auxilio Mutuo Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT03019640What this trial is testingUmbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's LymphomaWho this might be right forMantle Cell LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+4 more M.D. Anderson Cancer Center 22
Post-approval studies (Phase 4)Study completedNCT01401491What this trial is testingTreatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and FluvoxamineWho this might be right forSchizophrenia Taipei Medical University Hospital 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT02846623What this trial is testingAtezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter SyndromeWho this might be right forChronic Lymphocytic LeukemiaRecurrent Transformed Chronic Lymphocytic LeukemiaRefractory Transformed Chronic Lymphocytic Leukemia+2 more M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT02044796What this trial is testingFilgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesWho this might be right forAcute Biphenotypic Leukemiade Novo Myelodysplastic SyndromePreviously Treated Myelodysplastic Syndrome+3 more Fred Hutchinson Cancer Center 199
Testing effectiveness (Phase 2)Looking for participantsNCT06855823What this trial is testingA Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCLWho this might be right forRelapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL) Sun Yat-sen University 33
Early research (Phase 1)Study completedNCT04322292What this trial is testingBCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple MyelomaWho this might be right forMultiple Myeloma Institute of Hematology & Blood Diseases Hospital, China 9